Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-10-06 COHEN MARC A Director Conversion +1,482,183 1,852,207
2020-10-06 COHEN MARC A Director Conversion +2,484,425 2,484,425
2020-10-06 COHEN MARC A Director Purchase +5,030 $19.00 $96K 5,030
2020-10-06 COHEN MARC A Director Conversion · Series Seed Preferred Stock −2,000,000 0
2020-10-06 COHEN MARC A Director Conversion · Series A Preferred Stock −12,500,000 0
2020-10-06 COHEN MARC A Director Conversion · Series B Preferred Stock −20,952,403 0
2020-10-06 Anderson Kenneth Carl Director Conversion +18,040 80,376
2020-10-06 Anderson Kenneth Carl Director Conversion +18,040 45,038
2020-10-06 Anderson Kenneth Carl Director Conversion +41,244 63,543
2020-10-06 Anderson Kenneth Carl Director Conversion +41,244 63,543
2020-10-06 Anderson Kenneth Carl Director Conversion +16,939 16,939
2020-10-06 Anderson Kenneth Carl Director Conversion +16,939 16,939
2020-10-06 Anderson Kenneth Carl Director Conversion · Series A Preferred Stock −152,160 0
2020-10-06 Anderson Kenneth Carl Director Conversion · Series A Preferred Stock −152,160 0
2020-10-06 Anderson Kenneth Carl Director Conversion · Series A Preferred Stock −347,840 0
2020-10-06 Anderson Kenneth Carl Director Conversion · Series A Preferred Stock −347,840 0
2020-10-06 Anderson Kenneth Carl Director Conversion · Series B Preferred Stock −142,857 0
2020-10-06 Anderson Kenneth Carl Director Conversion · Series B Preferred Stock −142,857 0
2020-10-06 DOWNEY BRUCE Director Conversion +237,148 237,148
2020-10-06 DOWNEY BRUCE Director Conversion +252,394 489,542

Page 25 of 27 · 525 trades